Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001185185-10-000508
Filing Date
2010-05-11
Accepted
2010-05-11 14:47:42
Documents
5
Period of Report
2009-07-31

Document Format Files

Seq Description Document Type Size
1 lightlakethera10ka2-073109.htm 10-K/A 501557
2 ex31-1.htm EX-31.1 10857
3 ex31-2.htm EX-31.2 10956
4 ex32-1.htm EX-32.1 5958
5 ex32-2.htm EX-32.2 6507
  Complete submission text file 0001185185-10-000508.txt   537330
Mailing Address 225-230 QUEENS QUAY W. TORONTO A6 M5J 2Y7
Business Address 225-230 QUEENS QUAY W. TORONTO A6 M5J 2Y7 416-841-5414
Lightlake Therapeutics Inc. (Filer) CIK: 0001385508 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-K/A | Act: 34 | File No.: 333-139915 | Film No.: 10820540
SIC: 1000 Metal Mining